SCHEMBL915049

SCHEMBL915049

FS(F)(F)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.47
APOBEC3G Q9HC16 1/20 0.43
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CA7 P43166 3/20 0.43
ALDH1A1 P00352 2/20 0.43
CA12 O43570 2/20 0.43
CA13 Q8N1Q1 2/20 0.43
CA4 P22748 2/20 0.43
CA6 P23280 2/20 0.43
CA5A P35218 2/20 0.43
CA14 Q9ULX7 2/20 0.43
CA5B Q9Y2D0 2/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CA3 P07451 1/20 0.43
PLA2G7 Q13093 1/20 0.43
CA9 Q16790 1/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL943498 0.97 HTR6 (0.45) HTR6APOBEC3GCA1CA2CA7
SCHEMBL7935363 0.79 HTR6 (0.47) HTR6APOBEC3GCA1CA2CA7
SCHEMBL19110981 0.73 HTR6 (0.58) HTR6APOBEC3GCA1CA2CA7
SCHEMBL20651138 0.73 HTR6 (0.43) HTR6APOBEC3GCA1CA2CA7
SCHEMBL17804300 0.73 HTR6 (0.43) HTR6APOBEC3GCA1CA2CA7
SCHEMBL323729 0.73 HTR6 (0.58) HTR6APOBEC3GCA1CA2CA7
SCHEMBL4580427 0.71 HTR6 (0.47) HTR6APOBEC3GCA1CA2CA7
Hydrochloric Acid SCHEMBL30184245 0.71 HTR6 (0.55) HTR6APOBEC3GCA1CA2CA7
Hydrochloric Acid SCHEMBL930597 0.71 HTR6 (0.55) HTR6APOBEC3GCA1CA2CA7
SCHEMBL19537583 0.69 HTR6 (0.53) HTR6APOBEC3GCA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113773246-B Preparation method of 2-substituted-4-trifluoromethylpyridine 山东省农药科学研究院 2023-03-31 CN claimed
CN-113773246-A Preparation method of 2-substituted-4-trifluoromethylpyridine 山东省农药科学研究院 2021-12-10 CN claimed
US-8203003-B2 4-fluoropyrrolidine-2-carbonyl fluoride compounds and their preparative methods UBE INDUSTRIES, LTD. (JP) 2012-06-19 US claimed
CN-101591371-B Method for preparing gemcitabine or gemcitabine analogue by halogen exchange fluorination JINKANG PHARMACEUTICAL TECHNOLOGY CO LTD 2012-05-30 CN claimed
US-20110275833-A1 Novel 4-Fluoropyrrolidine-2-Carbonyl Fluoride Compounds and Their Preparative Methods UBE INDUSTRIES, LTD. (JP) 2011-11-10 US claimed
US-20100234605-A1 METHODS AND COMPOSITIONS FOR PRODUCING DIFLUOROMETHYLENE-AND TRIFLUOROMETHYL-CONTAINING COMPOUNDS IM&T RESEARCH, INC. (US) 2010-09-16 US claimed
WO-2010081014-A1 NOVEL 4-FLUOROPYRROLIDINE-2-CARBONYL FLUORIDE COMPOUNDS AND THEIR PREPARATIVE METHODS IM&T RESEARCH, INC. (US) 2010-07-15 WO claimed
US-20100174096-A1 Methods for Production of Optically Active Fluoropyrrolidine Derivatives IM&T RESEARCH, INC. (US) 2010-07-08 US claimed
CN-101591371-A A kind of method for preparing gemcitabine or its analogue by halogen-exchange fluorination JINKANG PHARMACEUTICAL TECHNOL (CN) 2009-12-02 CN claimed
WO-2009076345-A1 METHODS AND COMPOSITIONS FOR PRODUCING DIFLUOROMETHYLENE-AND TRIFLUOROMETHYL-CONTAINING COMPOUNDS IM & T RESEARCH, INC. (US) 2009-06-18 WO claimed
CN-112062670-B Fluorination reagent and deoxidization fluorination method 三明市海斯福化工有限责任公司 2023-05-09 CN disclosed
CN-113773246-B Preparation method of 2-substituted-4-trifluoromethylpyridine 山东省农药科学研究院 2023-03-31 CN disclosed
EP-3560910-B1 METHOD FOR MANUFACTURING DIFLUOROMETHYLENE COMPOUND DAIKIN IND LTD (JP) 2023-03-29 EP disclosed
CN-112174761-B Fluorination method 三明市海斯福化工有限责任公司 2023-03-24 CN disclosed
EP-4097089-A1 TRIFLAZOLES AND METHODS OF MAKING THE SAME Trinapco, Inc (US) 2022-12-07 EP disclosed
US-4120961-A ANTIHELMINTICS, CNS ACITVITY E. MERCK (DE) 1978-10-17 US disclosed
US-4113867-A ANTHELMINTICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1978-09-12 US disclosed
US-4051243-A RING SUBSTITUTED PYRAZINO-ISOQUINOLINE DERIVATIVES AND THEIR PREPARATION MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) 1977-09-27 US disclosed
US-4001411-A ANTHELMINTICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) 1977-01-04 US disclosed
US-3976691-A Dialkylaminosulfur trifluorides as fluorinating agents E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275833-A1 Novel 4-Fluoropyrrolidine-2-Carbonyl Fluoride Compounds and Their Preparative Methods PFAS, AFF4, PAICS HTR6 2866/4885APOBEC3G 2449/4885CA1 701/4885
US-20100174096-A1 Methods for Production of Optically Active Fluoropyrrolidine Derivatives QDPR, FDPS, DPYD HTR6 1329/4885APOBEC3G 1926/4885CA1 2530/4885
US-20100234605-A1 METHODS AND COMPOSITIONS FOR PRODUCING DIFLUOROMETHYLENE-AND TRIFLUOROMETHYL-CONTAINING COMPOUNDS FDPS, PFAS, FBL HTR6 2664/4885APOBEC3G 744/4885CA1 2374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.